We randomly assigned , in a double-blind 1:1:1 fashion , 21,162 patients who had had a myocardial infarction 1 to 3 years earlier to ticagrelor at a dose of 90 mg twice daily , ticagrelor at a dose of 60 mg twice daily , or placebo .
